|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
MacDougald OA, Hwang CS, Fan H, Lane MD,
et al: Regulated expression of the obese gene product (leptin) in
white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA.
92:9034–9037. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Halaas JL, Gajiwala KS, Maffei M, et al:
Weight-reducing effects of the plasma protein encoded by the obese
gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang L and Li C: Leptin: a
multifunctional hormone. Cell Res. 10:81–92. 2000. View Article : Google Scholar
|
|
5
|
Bouloumié A, Drexler HC, Lafontan M and
Busse R: Leptin, the product of Ob gene, promotes angiogenesis.
Circ Res. 83:1059–1066. 1998.PubMed/NCBI
|
|
6
|
Sierra-Honigmann MR, Nath AK, Murakami C,
et al: Biological action of leptin as an angiogenic factor.
Science. 281:1683–1686. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Somasunder P, McFadden DW, Hileman SM and
Vona-Davis L: Leptin is a growth factor in cancer. J Surg Res.
116:337–349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bjorbaek C, Uotani S, da Silva B and Flier
JS: Divergent signaling capacities of the long and short isoforms
of the leptin receptor. J Biol Chem. 272:32686–32695. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tartaglia LA: The leptin receptor. J Biol
Chem. 272:6093–6096. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saxena NK, Sharma D, Ding X, et al:
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling
is involved in leptin-mediated promotion of invasion and migration
of hepatocellular carcinoma cells. Cancer Res. 67:2497–2507. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin N, Wang D, Zhang H, et al: Molecular
mechanisms involved in the growth stimulation of breast cancer
cells by leptin. Cancer Res. 64:5870–5875. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan Y, Wang X, Lu J, et al: Effects of
leptin on biological behavior of cervical cancer Hela cells and its
mechanism. Chin J Clin Exp Pathol. 28:162–165. 2012.(In
Chinese).
|
|
13
|
Elbashir SM, Harborth J, Weber K and
Tuschl T: Analysis of gene function in somatic mammalian cells
using small interfering RNAs. Methods. 26:199–213. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoda MR, Keely SJ, Bertelsen LS, Junger
WG, Dharmasena D and Barrett KE: Leptin acts as a mitogenic and
antiapoptotic factor for colonic cancer cells. Br J Surg.
94:346–354. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ogunwobi OO and Beales IL: The
anti-apoptotic and growth stimulatory actions of leptin in human
colon cancer cells involves activation of JNK mitogen activated
protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis.
22:401–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pai R, Lin C, Tran T and Tarnawski A:
Leptin activates STAT and ERK2 pathways and induces gastric cancer
cell proliferation. Biochem Biophys Res Commun. 331:984–992. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koda M, Sulkowska M, Wincewicz A,
Kanczuga-Koda L, Musiatowicz B, Szymanska M and Sulkowski S:
Expression of leptin, leptin receptor, and hypoxia-inducible factor
1 alpha in human endometrial cancer. Ann NY Acad Sci. 1095:90–98.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi JH, Park SH, Leung PC and Choi KC:
Expression of leptin receptors and potential effects of leptin on
the cell growth and activation of mitogen-activated protein kinases
in ovarian cancer cells. J Clin Endocrinol Metab. 90:207–210. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin - a growth factor in normal and malignant breast cells and
for normal mammary gland development. J Natl Cancer Inst.
94:1704–1711. 2002. View Article : Google Scholar
|
|
21
|
Mauro L, Catalano S, Bossi G, et al:
Evidences that leptin up-regulates E-cadherin expression in breast
cancer: effects on tumor growth and progression. Cancer Res.
67:3412–3421. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rouet-Benzineb P, Aparicio T, Guilmeau S,
Pouzet C, Descatoire V, Buyse M and Bado A: Leptin counteracts
sodium butyrate-induced apoptosis in human colon cancer HT-29 cells
via NF-κB signaling. J Biol Chem. 279:16495–16502. 2004.PubMed/NCBI
|
|
23
|
Escobar-Morreale HF and San Millán JL:
Abdominal adiposity and the polycystic ovary syndrome. Trends
Endocrinol Metab. 18:266–272. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sharma D, Saxena NK, Vertino PM and Anania
FA: Leptin promotes the proliferative response and invasiveness in
human endometrial cancer cells by activating multiple
signal-transduction pathways. Endocr Relat Cancer. 13:629–640.
2006. View Article : Google Scholar
|
|
25
|
Sheiness D, Fanshier L and Bishop JM:
Identification of nucleotide sequences which may encode the
oncogenic capacity of avian retrovirus MC29. J Virol. 28:600–610.
1978.PubMed/NCBI
|
|
26
|
Persson H and Leder P: Nuclear
localization and DNA binding properties of a protein expressed by
human c-myc oncogene. Science. 225:718–721. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vita M and Henriksson M: The Myc
oncoprotein as a therapeutic target for human cancer. Semin Cancer
Biol. 16:318–330. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
O’Connell BC, Cheung AF, Simkevich CP, Tam
W, Ren X, Mateyak MK and Sedivy JM: A large scale genetic analysis
of c-Myc-regulated gene expression patterns. J Biol Chem.
278:12563–12573. 2003.PubMed/NCBI
|
|
29
|
Nesbit CE, Tersak JM and Prochownik EV:
MYC oncogenes and human neoplastic disease. Oncogene. 18:3004–3016.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chung HJ and Levens D: c-myc expression:
keep the noise down! Mol Cells. 20:157–166. 2005.PubMed/NCBI
|
|
31
|
Skirnisdóttir I, Seidal T, Gerdin E and
Sorbe B: The prognostic importance of p53, bcl-2, and bax in early
stage epithelial ovarian carcinoma treated with adjuvant
chemotherapy. Int J Gynecol Cancer. 12:265–276. 2002.PubMed/NCBI
|
|
32
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chung TK, Cheung TH, Lo WK, et al:
Expression of apoptotic regulators and their significance in
cervical cancer. Cancer Lett. 180:63–68. 2002. View Article : Google Scholar : PubMed/NCBI
|
